The FAM177A1 Research Fund has the opportunity to partner with  CURE Epilepsy to fund a grant up to $100,000.00 to advance our research. 

​

🔍 Our research initiatives include:

​

1️⃣ Developing patient-derived cell lines to unravel FAM177A1 loss-of-function mechanisms and test gene therapy effectiveness.

​

2️⃣ Establishing drug repurposing assays to find potential treatments and crafting gene therapy strategies.

​

3️⃣ Utilizing patient databases to define clinical phenotypes, develop biomarkers, and capture symptomatology.

​

Timelines: 

May 14, 2024: Request for Proposals Opens

June 11, 2024: Letters of Intent Deadline

June 26, 2024: Fill Application Invitations

July 26, 2024: Full Application Deadline

Dec 2024-Jan 2025: Anticipated Awardee Notification

Spring 2025: Earliest Award Start Date

​

More information about the grant can be found on the CURE Epilepsy website here. 

 

Submit your proposals here.

​

​

​

​